NLS Pharmaceutics Ltd. ("NLS") (Nasdaq: NLSP), a Swiss clinical-stage biopharmaceutical company focused on the discovery and development of innovative therapies for rare and complex central ...

As part of the share exchange process related to the merger, NLS is providing information about NLS's securities offering to Kadimastem shareholders. This announcement follows the Report on Form 6 ...

NLS Pharmaceutics and Kadimastem have filed a Registration Statement with the SEC in preparation for a proposed merger, creating a Nasdaq-traded biotechnology entity. This merger aims to leverage ...

Protein folding is the process by which proteins achieve their mature functional (native) tertiary structure, and often begins co-translationally. Protein folding requires chaperones and often ...